Wegovy and Zepbound rival targeting ‘next generation’ of obesity drugs, Zealand Pharma CEO says

Danish biotech Zealand Pharma is targeting the "next generation" of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly.



Source link